Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Lucid Diagnostics Inc.

    NASDAQ: LUCD · Real-Time Price · USD
    1.26
    -0.03 (-2.33%)
    At close: Jun 16, 2025, 3:59 PM
    1.28
    1.19%
    After-hours: Jun 16, 2025, 07:44 PM EDT

    Lucid Diagnostics Statistics

    Share Statistics

    Lucid Diagnostics has 108.19M shares outstanding. The number of shares has increased by 65.7% in one year.

    Shares Outstanding

    n/a
    		 108.19M

    Shares Change (YoY)

    n/a
    		 65.7%

    Shares Change (QoQ)

    n/a
    		 46.36%

    Owned by Institutions (%)

    n/a
    		 6.57%

    Shares Floating

    n/a
    		 40.34M

    Failed to Deliver (FTD) Shares

    n/a
    		 29,202

    FTD / Avg. Volume

    n/a
    		 2.44%

    Short Selling Information

    The latest short interest is 1.08M, so 1.06% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 1.08M

    Short % of Shares Out

    n/a
    		 1.06%

    Short % of Float

    n/a
    		 1.66%

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    The PE ratio is -0.91 and the forward PE ratio is -3.92. Lucid Diagnostics's PEG ratio is 0.02.

    PE Ratio

    n/a
    		 -0.91

    Forward PE

    n/a
    		 -3.92

    PS Ratio

    n/a
    		 9.52

    Forward PS

    n/a
    		 2.8

    PB Ratio

    n/a
    		 0.01

    P/FCF Ratio

    n/a
    		 -0.92

    PEG Ratio

    n/a
    		 0.02
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Lucid Diagnostics.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 1069.04, with a Debt / Equity ratio of 0.

    Current Ratio

    n/a
    		 1069.04

    Quick Ratio

    n/a
    		 1069.02

    Debt / Equity

    n/a
    		 0

    Debt / EBITDA

    n/a
    		 -0.48

    Debt / FCF

    n/a
    		 -0.47

    Interest Coverage

    n/a
    		 -1771.23

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $60,361.11

    Profits Per Employee

    n/a
    		 $-632,347.22

    Employee Count

    n/a
    		 72

    Asset Turnover

    n/a
    		 0.14

    Inventory Turnover

    n/a
    		 20.82

    Taxes

    Income Tax

    n/a
    		 7.5B

    Effective Tax Rate

    n/a
    		 -16464.23%

    Stock Price Statistics

    The stock price has increased by 77.39% in the last 52 weeks. The beta is 1.32, so Lucid Diagnostics's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.32

    52-Week Price Change

    n/a
    		 77.39%

    50-Day Moving Average

    n/a
    		 1.3

    200-Day Moving Average

    n/a
    		 1.08

    Relative Strength Index (RSI)

    n/a
    		 45.92

    Average Volume (20 Days)

    n/a
    		 1,196,773

    Income Statement

    In the last 12 months, Lucid Diagnostics had revenue of 4.35M and earned -45.53M in profits. Earnings per share was -1.05.

    Revenue

    n/a
    		 4.35M

    Gross Profit

    n/a
    		 -3.92M

    Operating Income

    n/a
    		 -46.05M

    Net Income

    n/a
    		 -45.53M

    EBITDA

    n/a
    		 -44.34M

    EBIT

    n/a
    		 -45.5M

    Earnings Per Share (EPS)

    n/a
    		 -1.05
    Full Income Statement

    Balance Sheet

    The company has 22.36M in cash and 21.25M in debt, giving a net cash position of 1.1M.

    Cash & Cash Equivalents

    n/a
    		 22.36M

    Total Debt

    n/a
    		 21.25M

    Net Cash

    n/a
    		 1.1M

    Retained Earnings

    n/a
    		 -203.77B

    Total Assets

    n/a
    		 32.8B

    Working Capital

    n/a
    		 -9.03B
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -44.14M and capital expenditures -646K, giving a free cash flow of -44.79M.

    Operating Cash Flow

    n/a
    		 -44.14M

    Capital Expenditures

    n/a
    		 -646K

    Free Cash Flow

    n/a
    		 -44.79M

    FCF Per Share

    n/a
    		 -0.89
    Full Cash Flow Statement

    Margins

    Gross margin is -90.2%, with operating and profit margins of -1059.64% and -1047.61%.

    Gross Margin

    n/a
    		 -90.2%

    Operating Margin

    n/a
    		 -1059.64%

    Pretax Margin

    n/a
    		 -1047.61%

    Profit Margin

    n/a
    		 -1047.61%

    EBITDA Margin

    n/a
    		 -1020.16%

    EBIT Margin

    n/a
    		 -1059.64%

    FCF Margin

    n/a
    		 -1030.51%

    Dividends & Yields

    LUCD does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for LUCD is $3, which is 138.1% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $3

    Price Target Difference

    n/a
    		 138.1%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 4
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -11.8

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist